5T V.K Pandiyan and CMO of odisha visited the biologix vaccine plant in Odisha biotech park in andharua, Bhubaneswar. With the manufacturer of cholera and malaria vaccination in odisha, The reputation will grow in the field off biotechnology and life will be saved.

The sapigen biologix vaccine plant, first such facility in state will start commercial vaccine production. After visiting the biologix vaccine plant v. karthik pandian and CMO informed on Sunday.

It is worth mentioning that the commercial production will start from vaccine plant by end of may this year.

1500 Direct employment will be creat in vaccine plant as DR .Krishna ELLA of Bharat biotech is came up with rs 1500 corers, and in the statement chief minister office said that: Most of employed are being selected from local area from odisha. And production capacity has been 2.4 corer doses of vaccine in a day.

The primary objective to design this vaccine plant is to targeting disease i.e. Malaria, cholera and including 13+ diseases and to produce disparate range of vaccine to cure these diseases.

One of the most attractive features of the sapigen biologix vaccine plant is its global outlook. The manufactured of vaccine not only to fulfilling domestic demand but it will also reach out globally.

And pandian hope for a comprehensive support from the govt highlighting the recently approved biotechnology policy CMO nabin Pttnaik cabinet.There is a expectation of a major job creation in the specialization field of biotechnology as the chair person expressed confident that creating this new venture plant may attracted to different complementary biotechnology company to the odisha biotech park